Who invested in Relmada Therapeutics?
Relmada Therapeutics's investors include Ben Franklin Technology Partners of Southeastern Pennsylvania and BioAdvance.
United States · Venture startup
4 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Relmada Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$26Mraised across 4 rounds since 2012, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $15M sold, first sale May 2014
No investor was named in the report.
Reported by finsmes.comSEC filing: $180K sold, first sale Dec 2012
No investor was named in the report.
Reported by sec.govSEC filing: $180K sold, first sale Dec 2012
Reported by finsmes.comSEC filing: $3.0M sold, first sale Jul 2012
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Relmada Therapeutics's investors include Ben Franklin Technology Partners of Southeastern Pennsylvania and BioAdvance.
Relmada Therapeutics has raised $26M across 4 rounds since 2012.
Relmada Therapeutics's most recent round was a Venture of $15M in May 2014.
Its most recent round, $15M in May 2014, is also its largest on record.
Relmada Therapeutics's first round on record, in Jul 2012, was backed by Ben Franklin Technology Partners of Southeastern Pennsylvania and BioAdvance.
Relmada Therapeutics's latest named round is a Venture, in May 2014.
Relmada Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.